Alnylam Pharmaceuticals, Inc. (ALNY) Reports Q3 Loss of 31c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 174.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $174.00 | 52 Week High | $109.10 | |||
| Open | $174.00 | 52 Week Low | $31.38 | |||
| Day High | $174.00 | P/E | N/A | |||
| Day Low | $174.00 | EPS | $-1.45 | |||
| Volume | 5,407 | |||||
